Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)

Market Cap	4.04B
Revenue (ttm)	2.28B
Net Income (ttm)	268.54M
Shares Out	100.99M
EPS (ttm)	2.64
PE Ratio	15.15
Forward PE	n/a
Dividend	1.60 (4.16%)
Ex-Dividend Date	Jul 3, 2025

Volume	791,219
Average Volume	189,889
Open	38.45
Previous Close	38.45
Day's Range	37.25 - 40.70
52-Week Range	30.00 - 45.20
Beta	0.22
RSI	78.09
Earnings Date	Nov 6, 2025

About Nang Kuang Pharmaceutical

Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion bags. It also provides various products in the areas of cardiovascular, gastrointestinal, nervous, musculo-skeletal, and respiratory system, as well as...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1963
• Employees: 552
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1752

Financial Performance

In 2024, Nang Kuang Pharmaceutical's revenue was 2.20 billion, an increase of 2.31% compared to the previous year's 2.15 billion. Earnings were 243.41 million, an increase of 22.68%.